The study has identified novel HU-induced miRNA that specifically target HbF regulatory genes (BCL11A, MYB, KLF-3, and SP1), and are therefore strong candidates for post-transcriptional therapeutic exploration in SCD. This evidence concerns the gene BCL11A and Schnyder corneal dystrophy.